MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.
Wang J, Shang Z, Wang J, Xu J, Li W, Guan Y, Yang L, Zhang W, Shen K, Zhang M, Wang J, Chen L, Li Q, He C, Wang N, Huang L, Xiao Y, Xiao M, Zhou J.
Wang J, et al. Among authors: xiao y, xiao m.
J Immunother Cancer. 2021 Jun;9(6):e002029. doi: 10.1136/jitc-2020-002029.
J Immunother Cancer. 2021.
PMID: 34078654
Free PMC article.
No abstract available.